The effects of thioridazine on the QTc interval - cardiovascular safety in a South African setting
Background. Thioridazine has long been used as a first-line antipsychotic in South Africa without any apparent problems. Recently the American Food and Drug Administration (FDA) and Novartis have warned of potentially lethal arrhythmias that may result from the use of thioridazine. Abnormal QT-inter...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2005-09-01
|
| Series: | South African Journal of Psychiatry |
| Online Access: | http://www.sajp.org.za/index.php/sajp/article/view/97 |